CVS Health Co. (NYSE:CVS) Stock Position Raised by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund raised its position in shares of CVS Health Co. (NYSE:CVS) by 5.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 310,294 shares of the pharmacy operator’s stock after purchasing an additional 17,332 shares during the period. Illinois Municipal Retirement Fund’s holdings in CVS Health were worth $24,501,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CVS. Bryn Mawr Capital Management LLC increased its position in CVS Health by 74.0% in the 3rd quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator’s stock worth $3,017,000 after buying an additional 18,385 shares during the period. Value Partners Investments Inc. increased its position in CVS Health by 26.5% in the 3rd quarter. Value Partners Investments Inc. now owns 991,601 shares of the pharmacy operator’s stock worth $69,261,000 after buying an additional 207,702 shares during the period. Sonora Investment Management Group LLC increased its position in CVS Health by 1.6% in the 3rd quarter. Sonora Investment Management Group LLC now owns 50,488 shares of the pharmacy operator’s stock worth $3,525,000 after buying an additional 774 shares during the period. Checchi Capital Advisers LLC increased its position in CVS Health by 2.3% in the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock worth $726,000 after buying an additional 233 shares during the period. Finally, Personal CFO Solutions LLC increased its position in CVS Health by 2.6% in the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after buying an additional 491 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Trading Down 0.2 %

Shares of CVS stock traded down $0.14 on Monday, reaching $69.61. 5,699,562 shares of the stock were exchanged, compared to its average volume of 10,787,651. The stock has a market cap of $87.74 billion, a PE ratio of 10.78, a P/E/G ratio of 0.92 and a beta of 0.52. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a 50 day moving average price of $75.13 and a 200 day moving average price of $73.77.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. The business had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.99 earnings per share. Equities research analysts forecast that CVS Health Co. will post 8.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.82%. CVS Health’s dividend payout ratio is presently 41.18%.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent analyst reports. Piper Sandler lifted their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Barclays assumed coverage on CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective on the stock. Wells Fargo & Company decreased their price objective on CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a report on Monday, April 8th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research note on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $89.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.